Amanote Research
Register
Sign In
Role of MRP1 in Multidrug Resistance in Acute Myeloid Leukemia
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2401361
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
April 1, 1999
Authors
O Legrand
R Zittoun
J-P Marie
Publisher
Springer Science and Business Media LLC
Related search
Activity and Expression of the Multidrug Resistance Proteins P-Glycoprotein, MRP1, MRP2, MRP3 and MRP5 in De Novo and Relapsed Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Evidence of a Role for Functional Heterogeneity in Multidrug Resistance Transporters in Clinical Trials of P-Glycoprotein Modulation in Acute Myeloid Leukemia
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Progress in Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
WNT/Β‑catenin Inhibition Reverses Multidrug Resistance in Pediatric Acute Lymphoblastic Leukemia
Oncology Reports
Medicine
Cancer Research
Oncology
The Role of TP53 in Acute Myeloid Leukemia: Challenges and Opportunities
Genes Chromosomes and Cancer
Cancer Research
Genetics
Acute Myeloid Leukemia
JAMA - Journal of the American Medical Association
Medicine
Acute Myeloid Leukemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Multidrug Resistance Protein 4/ ATP Binding Cassette Transporter 4: A New Potential Therapeutic Target for Acute Myeloid Leukemia
Oncotarget
Oncology
Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?
Therapeutic Advances in Hematology
Hematology
